StockData
SCYNEXIS Inc logo

SCYNEXIS Inc (SCYX) stock

SCYXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3072% below fair value
$2.82−0.03 (-1.05%)

Close on Nov 18, 2026Market cap $28.06MP/E –Yield –

Scynexis pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Scynexis's pe ratio was 1.1× on Jul 31, 2024.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2024Jul 31, 20241.1×−0.5
2023Dec 29, 20231.6×–

More Scynexis figures

See a number that looks wrong?